메뉴 건너뛰기




Volumn 23, Issue 12, 2005, Pages 2661-2668

Pentostatin in steroid-refractory acute graft-versus-host disease

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DACLIZUMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOSTATIN; PSORALEN; STEROID; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

EID: 21044441501     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.06.130     Document Type: Article
Times cited : (109)

References (42)
  • 1
    • 0028779536 scopus 로고
    • Bone marrow transplantation
    • Armitage JO: Bone marrow transplantation. N Engl J Med 330:827-838, 1994
    • (1994) N Engl J Med , vol.330 , pp. 827-838
    • Armitage, J.O.1
  • 3
    • 0036210985 scopus 로고    scopus 로고
    • Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment
    • Arai S, Margolis J, Zahurak M, et al: Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment. Biol Blood Marrow Transplant 8:155-160, 2002
    • (2002) Biol Blood Marrow Transplant , vol.8 , pp. 155-160
    • Arai, S.1    Margolis, J.2    Zahurak, M.3
  • 4
    • 0034307671 scopus 로고    scopus 로고
    • Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: A pilot study
    • Greinix HT, Volc-Platzer B, Knobler RM, et al: Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: A pilot study. Blood 96:477A, 2000
    • (2000) Blood , vol.96
    • Greinix, H.T.1    Volc-Platzer, B.2    Knobler, R.M.3
  • 5
    • 0035496916 scopus 로고    scopus 로고
    • Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL
    • Deeg HJ, Blazar BR, Bolwell BJ, et al: Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL. Blood 98:2052-2058, 2001
    • (2001) Blood , vol.98 , pp. 2052-2058
    • Deeg, H.J.1    Blazar, B.R.2    Bolwell, B.J.3
  • 6
    • 0037089222 scopus 로고    scopus 로고
    • A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease
    • Carpenter PA, Appelbaum FR, Corey L, et al: A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease. Blood 99:2712-2719, 2002
    • (2002) Blood , vol.99 , pp. 2712-2719
    • Carpenter, P.A.1    Appelbaum, F.R.2    Corey, L.3
  • 7
    • 0025190044 scopus 로고
    • Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: An analysis of clinical risk features and outcome
    • Weisdorf D, Haake R, Blazar B, et al: Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: An analysis of clinical risk features and outcome. Blood 75:1024-1030, 1990
    • (1990) Blood , vol.75 , pp. 1024-1030
    • Weisdorf, D.1    Haake, R.2    Blazar, B.3
  • 8
    • 0026757709 scopus 로고
    • Acute graft-versus-host disease following unrelated donor marrow transplantation: Failure of conventional therapy
    • Roy J, McGlave PB, Filipovich AH, et al: Acute graft-versus-host disease following unrelated donor marrow transplantation: Failure of conventional therapy. Bone Marrow Transplant 10:77-82, 1992
    • (1992) Bone Marrow Transplant , vol.10 , pp. 77-82
    • Roy, J.1    McGlave, P.B.2    Filipovich, A.H.3
  • 9
    • 0025731169 scopus 로고
    • A retrospective analysis of therapy for acute graft-versus-host disease: Secondary treatment
    • Martin PJ, Schoch G, Fisher L, et al: A retrospective analysis of therapy for acute graft-versus-host disease: Secondary treatment. Blood 77:1821-1828, 1991
    • (1991) Blood , vol.77 , pp. 1821-1828
    • Martin, P.J.1    Schoch, G.2    Fisher, L.3
  • 10
    • 0028010849 scopus 로고
    • Newer purine analogues for the treatment of hairy-cell leukemia
    • Saven A, Piro L: Newer purine analogues for the treatment of hairy-cell leukemia. N Engl J Med 330:691-697, 1994
    • (1994) N Engl J Med , vol.330 , pp. 691-697
    • Saven, A.1    Piro, L.2
  • 11
    • 0015515283 scopus 로고
    • Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity
    • Giblett ER, Anderson JE, Cohen F, et al: Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2:1067-1069, 1972
    • (1972) Lancet , vol.2 , pp. 1067-1069
    • Giblett, E.R.1    Anderson, J.E.2    Cohen, F.3
  • 12
    • 0023109354 scopus 로고
    • Inhibition of lymphocyte-specific enzymes: A promising approach for selective immunosuppression
    • Ruers TJ, Buurman WA, van der Linden CJ, et al: Inhibition of lymphocyte-specific enzymes: A promising approach for selective immunosuppression. Transplant Proc 19:1287-1289, 1987
    • (1987) Transplant Proc , vol.19 , pp. 1287-1289
    • Ruers, T.J.1    Buurman, W.A.2    van der Linden, C.J.3
  • 13
    • 0026710706 scopus 로고
    • Adenosine-deaminase-associated immunodeficiency. I. Differential sensitivities of lymphocyte subpopulations exposed to 2-deoxycoformycin in vivo
    • Bagasra O, Howeedy A, Pomerantz RJ: Adenosine-deaminase-associated immunodeficiency. I. Differential sensitivities of lymphocyte subpopulations exposed to 2-deoxycoformycin in vivo. Clin Exp Immunol 88:383-388, 1992
    • (1992) Clin Exp Immunol , vol.88 , pp. 383-388
    • Bagasra, O.1    Howeedy, A.2    Pomerantz, R.J.3
  • 14
    • 0020699835 scopus 로고
    • Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine
    • Grever MR, Siaw MF, Coleman MS, et al: Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine. J Immunol 130:365-369, 1983
    • (1983) J Immunol , vol.130 , pp. 365-369
    • Grever, M.R.1    Siaw, M.F.2    Coleman, M.S.3
  • 15
  • 16
    • 0031052623 scopus 로고    scopus 로고
    • Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up
    • Seymour JF, Talpaz M, Kurzrock R: Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up. Leukemia 11:42-47, 1997
    • (1997) Leukemia , vol.11 , pp. 42-47
    • Seymour, J.F.1    Talpaz, M.2    Kurzrock, R.3
  • 17
    • 0024595398 scopus 로고
    • Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia
    • Urba WJ, Baseler MW, Kopp WC, et al: Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia. Blood 73:38-46, 1989
    • (1989) Blood , vol.73 , pp. 38-46
    • Urba, W.J.1    Baseler, M.W.2    Kopp, W.C.3
  • 18
    • 0023006839 scopus 로고
    • Prevention of graft-versus-host disease in allogeneic bone marrow transplantation by pre-treatment with 2′-deoxycoformycin
    • Epstein J, Bealmear PM, Kennedy DW, et al: Prevention of graft-versus-host disease in allogeneic bone marrow transplantation by pre-treatment with 2′-deoxycoformycin. Exp Hematol 14:845-849, 1986
    • (1986) Exp Hematol , vol.14 , pp. 845-849
    • Epstein, J.1    Bealmear, P.M.2    Kennedy, D.W.3
  • 19
    • 2442642825 scopus 로고    scopus 로고
    • A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease
    • Miller KB, Roberts TF, Chan G, et al: A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease. Bone Marrow Transplant 33:881-889, 2004
    • (2004) Bone Marrow Transplant , vol.33 , pp. 881-889
    • Miller, K.B.1    Roberts, T.F.2    Chan, G.3
  • 20
    • 0019835363 scopus 로고
    • Effect of 2′-deoxycoformycin on erythroid, granulocytic, and T-lymphocyte colony growth
    • Aye MT, Dunne JV: Effect of 2′-deoxycoformycin on erythroid, granulocytic, and T-lymphocyte colony growth. Blood 58:1043-1046, 1981
    • (1981) Blood , vol.58 , pp. 1043-1046
    • Aye, M.T.1    Dunne, J.V.2
  • 21
    • 0021321053 scopus 로고
    • An enzymatic kinetic method for the determination of 2′-deoxycoformycin in biological fluids
    • Staubus AE, Weinrib AB, Malspeis L: An enzymatic kinetic method for the determination of 2′-deoxycoformycin in biological fluids. Biochem Pharmacol 33:1633-1637, 1984
    • (1984) Biochem Pharmacol , vol.33 , pp. 1633-1637
    • Staubus, A.E.1    Weinrib, A.B.2    Malspeis, L.3
  • 22
    • 0019127565 scopus 로고
    • The clinical pharmacology of the adenosine deaminase inhibitor 2′-deoxycoformycin
    • Smyth JF, Paine RM, Jackman AL, et al: The clinical pharmacology of the adenosine deaminase inhibitor 2′-deoxycoformycin. Cancer Chemother Pharmacol 5:93-101, 1980
    • (1980) Cancer Chemother Pharmacol , vol.5 , pp. 93-101
    • Smyth, J.F.1    Paine, R.M.2    Jackman, A.L.3
  • 23
    • 0019521591 scopus 로고
    • Clinical pharmacology of deoxycoformycin
    • Major PP, Agarwal RP, Kufe DW: Clinical pharmacology of deoxycoformycin. Blood 58:91-96, 1981
    • (1981) Blood , vol.58 , pp. 91-96
    • Major, P.P.1    Agarwal, R.P.2    Kufe, D.W.3
  • 24
    • 0019835982 scopus 로고
    • Levels of 2′-deoxycoformycin, adenosine, and deoxyadenosine in patients with acute lymphoblastic leukemia
    • Venner PM, Glazer RI, Blatt J, et al: Levels of 2′-deoxycoformycin, adenosine, and deoxyadenosine in patients with acute lymphoblastic leukemia. Cancer Res 41:4508-4511, 1981
    • (1981) Cancer Res , vol.41 , pp. 4508-4511
    • Venner, P.M.1    Glazer, R.I.2    Blatt, J.3
  • 25
    • 0021278791 scopus 로고
    • Clinical pharmacokinetics of 2′-deoxycoformycin
    • Malspeis L, Weinrib A, Staubus A, et al: Clinical pharmacokinetics of 2′-deoxycoformycin. Cancer Treat Symp 2:7-15, 1984
    • (1984) Cancer Treat Symp , vol.2 , pp. 7-15
    • Malspeis, L.1    Weinrib, A.2    Staubus, A.3
  • 26
    • 0021235975 scopus 로고
    • Pharmacology of 2′-deoxycoformycin and vidarabine
    • Agarwal R: Pharmacology of 2′-deoxycoformycin and vidarabine. Cancer Treat Symp 2:17-22, 1984
    • (1984) Cancer Treat Symp , vol.2 , pp. 17-22
    • Agarwal, R.1
  • 27
    • 0027422366 scopus 로고
    • Pentostatin: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders
    • Brogden RN, Sorkin EM: Pentostatin: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders. Drugs 46:652-677, 1993
    • (1993) Drugs , vol.46 , pp. 652-677
    • Brogden, R.N.1    Sorkin, E.M.2
  • 28
    • 0000099405 scopus 로고
    • Clinical pharmacokinetics of 2′-deoxycoformycin in renal impairment
    • abstr 361
    • Grever M, Staubus A, Balcerzak S, et al: Clinical pharmacokinetics of 2′-deoxycoformycin in renal impairment. Proc Am Soc Clin Oncol 12:140, 1993 (abstr 361)
    • (1993) Proc Am Soc Clin Oncol , vol.12 , pp. 140
    • Grever, M.1    Staubus, A.2    Balcerzak, S.3
  • 29
    • 0033909539 scopus 로고    scopus 로고
    • Clinical pharmacokinetics of nucleoside analogues: Focus on haematological malignancies
    • Johnson S: Clinical pharmacokinetics of nucleoside analogues: Focus on haematological malignancies. Clin Pharmacokinet 39:5-26, 2000
    • (2000) Clin Pharmacokinet , vol.39 , pp. 5-26
    • Johnson, S.1
  • 30
    • 0028844579 scopus 로고
    • Design and analysis of in vitro antitumor pharmacodynamic studies
    • Kalns JE, Millenbaugh NJ, Wientjes MG, et al: Design and analysis of in vitro antitumor pharmacodynamic studies. Cancer Res 55:5315-5322, 1995
    • (1995) Cancer Res , vol.55 , pp. 5315-5322
    • Kalns, J.E.1    Millenbaugh, N.J.2    Wientjes, M.G.3
  • 31
    • 0032190104 scopus 로고    scopus 로고
    • Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: A multicenter randomized trial from the Italian Group for Bone Marrow Transplantation
    • Van Lint MT, Uderzo C, Locasciulli A, et al: Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: A multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. Blood 92:2288-2293, 1998
    • (1998) Blood , vol.92 , pp. 2288-2293
    • Van Lint, M.T.1    Uderzo, C.2    Locasciulli, A.3
  • 32
    • 0028227814 scopus 로고
    • 2-Chlorodeoxyadenosine as treatment of severe acute graft-versus-host disease
    • Pless M, Gratwohl A, Tichelli A, et al: 2-Chlorodeoxyadenosine as treatment of severe acute graft-versus-host disease. Blood 84:987-989, 1994
    • (1994) Blood , vol.84 , pp. 987-989
    • Pless, M.1    Gratwohl, A.2    Tichelli, A.3
  • 33
    • 0024590995 scopus 로고
    • Pentostatin in the treatment of advanced hairy cell leukemia
    • Kraut EH, Bouroncle BA, Grever MR: Pentostatin in the treatment of advanced hairy cell leukemia. J Clin Oncol 7:168-172, 1989
    • (1989) J Clin Oncol , vol.7 , pp. 168-172
    • Kraut, E.H.1    Bouroncle, B.A.2    Grever, M.R.3
  • 34
    • 0035383814 scopus 로고    scopus 로고
    • Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation
    • Storek J, Dawson MA, Storer B, et al: Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 97:3380-3389, 2001
    • (2001) Blood , vol.97 , pp. 3380-3389
    • Storek, J.1    Dawson, M.A.2    Storer, B.3
  • 35
    • 0032726389 scopus 로고    scopus 로고
    • Persistent changes in the immune system 4-10 years after ABMT
    • Nordoy T, Kolstad A, Endresen P, et al: Persistent changes in the immune system 4-10 years after ABMT. Bone Marrow Transplant 24: 873-878, 1999
    • (1999) Bone Marrow Transplant , vol.24 , pp. 873-878
    • Nordoy, T.1    Kolstad, A.2    Endresen, P.3
  • 36
    • 0037019138 scopus 로고    scopus 로고
    • Clinical practice. Long-term care after hematopoietic-cell transplantation in adults
    • Antin JH: Clinical practice. Long-term care after hematopoietic-cell transplantation in adults. N Engl J Med 347:36-42, 2002
    • (2002) N Engl J Med , vol.347 , pp. 36-42
    • Antin, J.H.1
  • 37
    • 0030851117 scopus 로고    scopus 로고
    • ATG plus corticosteroid therapy for acute graft-versus-host disease: Predictors of response and survival
    • Dugan MJ, DeFor TE, Steinbuch M, et al: ATG plus corticosteroid therapy for acute graft-versus-host disease: Predictors of response and survival. Ann Hematol 75:41-46, 1997
    • (1997) Ann Hematol , vol.75 , pp. 41-46
    • Dugan, M.J.1    DeFor, T.E.2    Steinbuch, M.3
  • 38
    • 17844362706 scopus 로고    scopus 로고
    • Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin
    • Khoury H, Kashyap A, Adkins DR, et al: Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin. Bone Marrow Transplant 27:1059-1064, 2001
    • (2001) Bone Marrow Transplant , vol.27 , pp. 1059-1064
    • Khoury, H.1    Kashyap, A.2    Adkins, D.R.3
  • 40
    • 0035660613 scopus 로고    scopus 로고
    • Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease
    • Benito AI, Furlong T, Martin PJ, et al: Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease. Transplantation 72:1924-1929, 2001
    • (2001) Transplantation , vol.72 , pp. 1924-1929
    • Benito, A.I.1    Furlong, T.2    Martin, P.J.3
  • 41
    • 1642394033 scopus 로고    scopus 로고
    • Treatment of resistant acute and chronic graft versus host disease with mycophenolate mofetil
    • abstr
    • Abhyankar S, Godder K, Christiansen N. Treatment of resistant acute and chronic graft versus host disease with mycophenolate mofetil. Blood 92:340B, 1998 (abstr)
    • (1998) Blood , vol.92
    • Abhyankar, S.1    Godder, K.2    Christiansen, N.3
  • 42
    • 84871469628 scopus 로고    scopus 로고
    • Treatment of acute and chronic graft versus host disease with mycophenolate mofetil
    • Ilhan O, Celebi H, Aral M, et al: Treatment of acute and chronic graft versus host disease with mycophenolate mofetil. Blood 94:368B, 1999
    • (1999) Blood , vol.94
    • Ilhan, O.1    Celebi, H.2    Aral, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.